Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

This approval makes Ozempic the first GLP-1 treatment for patients with both conditions. Chronic kidney disease is common in people with diabetes. About one in three adults with diabetes have kidney ...

These drugs, called GLP1-RAs (short for glucagon-like peptide-1 receptor agonists), have been found to reduce hospital visits ...

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

Glomerular hyperfiltration may increase CVD risks, including myocardial infarction and heart failure, for patients with type ...

WASHINGTON — Ozempic, the blockbuster GLP-1 drug that was originally approved to treat Type 2 diabetes ... to the patients," Gough told CNN. "The impact on not just kidney disease but also ...